Currently, phenotypic characterization is routinely used in diagnostic laboratories for antibiotic resistance measurement due to its cost-effectiveness. With the advent of molecular diagnostic technologies that offer shorter turnaround times and more comprehensive data on antibiotic resistance, is there any chance that they will replace phenotyping and become standardized in practice?